2021_Spring_CMTA_Report

…Accelerate Research (STAR) project launched Strategy To Accelerate ResearchStrategy To Accelerate Research 2019 Stem cell studies published, first gene modifier and skin biopsy assay (treatment-responsive for CMT1A); CMT Health Index…

REPORT CONCEPTSPREADS72

…to provide information to patients, their families, doctors and researchers. THE RARE DISEASES CLINICAL RESEARCH NETWORK (RDCRN) RDCRN is an NIH-funded research network of 20 active consortia, each focused on…

CMT1A Ionis Press Release

researchers together with pharmaceutical partners—and donors willing to fund their research—so that scientific breakthroughs are possible. For more information about the research paper, please go to www.cmtausa.org. About the Charcot-Marie-Tooth…

Funding

…not be accepted After the CMTA Board of Directors acts, the CMTA will document, agree and sign off on the research plan with the research investigator institution. Evaluation Approach Project…

Keep Hope Alive for Everyone Living with CMT

…CMTA has invested over $17 million in CMTA-STAR research since 2008, making us the largest chartable funder of CMT research globally. But our work isn’t done: Our strategy outlines investments…

2022 Annual Report_spreads

research, community support and stewardship of funds. Since the CMTA instituted its Strategy to Accelerate Research (STAR) in 2008, the field of CMT research has grown by leaps and bounds….

CMTAreportspring24FINALwebSPREADS

…STAR (Strategy to Accelerate Research), our premier research initiative, as well as important community initiatives like Camp Footprint, Patient/Research Conferences, and educational programs. All of these programs require steady, reliable…